Hexagon Capital Partners LLC - VIR BIOTECHNOLOGY INC ownership

VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 222 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.

Quarter-by-quarter ownership
Hexagon Capital Partners LLC ownership history of VIR BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$2,961
-84.1%
316
-58.3%
0.00%
-80.0%
Q2 2023$18,594
+18.2%
758
+12.1%
0.01%
+25.0%
Q1 2023$15,731
-24.1%
676
-17.5%
0.00%
-33.3%
Q4 2022$20,729
+130.3%
819
+76.9%
0.01%
+100.0%
Q3 2022$9,000
+12.5%
463
+44.7%
0.00%
+50.0%
Q2 2022$8,000
-33.3%
320
+11.9%
0.00%
-33.3%
Q4 2021$12,0002860.00%
Other shareholders
VIR BIOTECHNOLOGY INC shareholders Q3 2022
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 1,559,142$30,100,00023.79%
SB INVESTMENT ADVISERS (UK) LTD 22,086,280$425,823,0003.26%
Zebra Capital Management LLC 40,104$773,0002.94%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 130,409$2,514,0000.94%
CLARK ESTATES INC/NY 180,000$3,470,0000.77%
Temasek Holdings (Private) Ltd 6,036,821$116,389,9090.70%
SECTOR GAMMA AS 89,808$1,731,0000.45%
Capital Impact Advisors, LLC 13,196$360,0000.36%
SummerHaven Investment Management, LLC 24,927$481,0000.33%
DUALITY ADVISERS, LP 92,712$1,787,0000.20%
View complete list of VIR BIOTECHNOLOGY INC shareholders